Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mitsushige Sugimoto"'
Autor:
Hiroyuki Odagiri, Waku Hatta, Yosuke Tsuji, Toshiyuki Yoshio, Yohei Yabuuchi, Daisuke Kikuchi, Shigetsugu Tsuji, Yasuaki Nagami, Takuto Hikichi, Masakuni Kobayashi, Yoshinori Morita, Tetsuya Sumiyoshi, Mikitaka Iguchi, Hideomi Tomida, Takuya Inoue, Tatsuya Mikami, Kenkei Hasatani, Jun Nishikawa, Tomoaki Matsumura, Hiroko Nebiki, Dai Nakamatsu, Ken Ohnita, Haruhisa Suzuki, Hiroya Ueyama, Yoshito Hayashi, Mitsushige Sugimoto, Shinjiro Yamaguchi, Tomoki Michida, Tomoyuki Yada, Yoshiro Asahina, Toshiaki Narasaka, Shiko Kuribayashi, Shu Kiyotoki, Katsuhiro Mabe, Mitsuhiro Fujishiro, Atsushi Masamune, Shu Hoteya
Publikováno v:
Digestion. 103:428-437
Introduction: Few studies have focused on bleeding following endoscopic submucosal dissection (ESD) in surgically altered stomach. We aimed to reveal the bleeding risk in surgically altered stomach following ESD for early gastric cancer (EGC). Method
Autor:
Akihito Nagahara, Ki Baik Hahm, Koji Otani, Akiko Shiotani, Tiing Leong Ang, Kazunari Murakami, Mitsushige Sugimoto, Toshio Watanabe, Maria Carla Tablante, Qi Zhu, Varayu Prachayakul, Shin Fukudo, Satoru Yamaguchi, Takeshi Kamiya, Murdani Abdullah, Satoshi Motoya, Akira Higashimori, Francis K.L. Chan, Hidekazu Suzuki
Publikováno v:
Digestion
Introduction: The COVID-19 outbreak abruptly restricted gastrointestinal (GI) endoscopy services during the first wave of the pandemic. We aimed to assess the impact of COVID-19 on the practice of GI endoscopy in Asian countries. Methods: This was an
Autor:
Kenichiro Takahashi, Akira Andoh, Masahiro Kawahara, Atsushi Nishida, Yasuhiro Morita, Mitsushige Sugimoto, Osamu Inatomi, Shigeki Bamba, Masaya Sasaki
Publikováno v:
Digestion. 100:238-246
Background/Aims: Thiopurines are key drugs in maintenance therapy for treating inflammatory bowel disease (IBD). Time-dependent 5-aminosalicylates (5-ASA) releasing preparations (time-dependent 5-ASA) increase 6-thioguanine nucleotide (6-TGN), an act
Autor:
Eiji Kubota, Akihito Nagahara, Takeshi Kamiya, Francis K.L. Chan, Ki Baik Hahm, Satoshi Motoya, Akiko Shiotani, Kazunari Murakami, Shin Fukudo, Satoru Yamaguchi, Mitsushige Sugimoto, Qi Zhu, Toshio Watanabe, Satoshi Osaga, Hidekazu Suzuki, Kwong Ming Fock
Publikováno v:
Digestion. 102(1)
Background/Aims: Functional gastrointestinal disorders (FGIDs) are diagnosed and classified using the latest Rome IV criteria, released in 2016. Epidemiology of FGID diagnosed by the Rome IV criteria and current clinical application of gastrointestin
Autor:
Akihiko Kato, Ken Sugimoto, Naro Ohashi, Takahisa Furuta, Hideo Yasuda, Mitsushige Sugimoto, Takuma Kagami, Yoshiaki Horio, Shu Sahara, Hitomi Ichikawa, Yukitoshi Sakao
Publikováno v:
Digestion. 97:163-169
Background: An optimum Helicobacter pylori-eradication regimen for hemodialysis patients is yet to be established because of different pharmacokinetics of amoxicillin involved between hemodialysis patients and healthy subjects. We investigated to est
Autor:
Yukitoshi Sakao, Hideo Yasuda, Naro Ohashi, Mitsushige Sugimoto, Shu Sahara, Akira Andoh, Ken Sugimoto, Hitomi Ichikawa, Takahisa Furuta
Publikováno v:
Digestion. 95:302-309
Introduction:Helicobacter pylori (H. pylori) infection is one of the major risk factors for gastrointestinal morbidity in hemodialysis patients. Primary end point is to investigate H. pylori infection rate in hemodialysis patients. As secondary end p
Autor:
Osamu Ogawa, Norihisa Ishimura, Kosuke Nomura, Hironobu Mikami, Seiji Arihiro, Toshifumi Mitani, Takumi Tanaka, Shinya Sakagami, Yasutaka Kuribayashi, Kosaku Nanki, Katsuyoshi Matsuoka, Ki Baik Hahm, Yasuhiro Fujiwara, Mitsushige Sugimoto, Yoshihiro Nakazato, Haruhiko Ogata, Isao Okayasu, Makoto Mutaguchi, Tetsuo Arakawa, Eiko Okimoto, Taro Watabe, Yoshikazu Kinoshita, Fuminori Moriyasu, Kiyoto Mori, Shinya Sugimoto, Qi Zhu, Yoshihiko Kawase, Hitomi Ichikawa, Naoki Hosoe, Hiroki Kiyohara, Shusei Ishida, Takahiro Uotani, Akihiro Yamada, Eiji Kubota, Toshiro Iizuka, Yasuharu Yamaguchi, Kazuo Ohtsuka, Yoshinori Arai, Ari Fahrial Syam, Abdul Aziz Rani, Takehide Fujimoto, Toshimitsu Fujii, Atsushi Nishida, Mitsuru Kaise, Jose D. Sollano, Ryoma Hayashi, Satoshi Yamashita, Kenichiro Takahashi, Shunji Ishihara, Fumiaki Ueno, Kazuhiko Uchiyama, Takashi Nagaishi, Akira Matsui, Makoto Naganuma, Akira Andoh, Hiromi Kataoka, Shigeki Bamba, Tsukasa Furuhata, Takanori Kanai, Masakazu Nagahori, Rieko Bessho, Mamoru Watanabe, Takahisa Furuta, Shin'ichi Takahashi, Hidekazu Suzuki, Kengo Tokunaga, Ryuuta Hiratsuka, Masaaki Matsuura, Makoto Fujii, Satoru Ito, Di Jin Jiao, Takahito Toba, Mutsunori Fujiwara, Nisha Jose, Takashi Kawai, Takashi Joh, Yasushi Iwao, Yuji Naito, Tomokazu Matsuura, Naoki Oshima, Keiko Ohno, Shin Fukudo, Yasuhisa Shinomura, Daisuke Kikuchi, Francis K.L. Chan, Makoto Shioya, Juntaro Matsuzaki, Osamu Inatomi, Tatsurou Tominaga, Nagamu Inoue, Yasuhiko Nagata, Druckerei Stückle, Udom Kachintorn, Shunji Takeuchi, Tadakazu Hisamatsu, Mari Arai, Hirotsugu Imaeda, Shu Hoteya, Shinta Mizuno, Kwong Ming Fock, Akihiko Tsuchida, Arisa Tokai, Akhiro Yamada
Publikováno v:
Digestion. 93:74-92
Publikováno v:
Digestion. 93:24-31
Background: The prevalence of gastroesophageal reflux disease (GERD) has increased in Japan since the end of the 20th century due to changes in environmental factors, such as a decreased infection rate of Helicobacter pylori and increased ability of
Autor:
Shu, Sahara, Mitsushige, Sugimoto, Hitomi, Ichikawa, Takuma, Kagami, Yukitoshi, Sakao, Naro, Ohashi, Yoshiaki, Horio, Ken, Sugimoto, Akihiko, Kato, Takahisa, Furuta, Hideo, Yasuda
Publikováno v:
Digestion. 97(2)
An optimum Helicobacter pylori-eradication regimen for hemodialysis patients is yet to be established because of different pharmacokinetics of amoxicillin involved between hemodialysis patients and healthy subjects. We investigated to establish appro
Autor:
Takahisa Furuta, Shu Sahara, Mihoko Yamade, Hitomi Ichikawa, Mitsushige Sugimoto, Takuma Kagami, Moriya Iwaizumi, Yasushi Hamaya, Ken Sugimoto, Satoshi Osawa, Takahiro Uotani, Hiroaki Miyajima
Publikováno v:
Digestion. 91:277-285
Background: When administered at a standard dose, proton pump inhibitors (PPIs) do not always provide sufficient acid inhibition for all subjects, particularly in extensive metabolizers (EMs) of CYP2C19. Whether esomeprazole at a dose of 20 mg four t